These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19737552)

  • 1. Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice.
    Tan Z; Dai T; Zhong X; Tian Y; Leppo MK; Gao WD
    Eur J Pharmacol; 2009 Oct; 621(1-3):71-7. PubMed ID: 19737552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy.
    Minhas KM; Saraiva RM; Schuleri KH; Lehrke S; Zheng M; Saliaris AP; Berry CE; Barouch LA; Vandegaer KM; Li D; Hare JM
    Circ Res; 2006 Feb; 98(2):271-9. PubMed ID: 16357304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure.
    Amado LC; Saliaris AP; Raju SV; Lehrke S; St John M; Xie J; Stewart G; Fitton T; Minhas KM; Brawn J; Hare JM
    J Mol Cell Cardiol; 2005 Sep; 39(3):531-6. PubMed ID: 15963530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.
    Cingolani HE; Plastino JA; Escudero EM; Mangal B; Brown J; Pérez NG
    J Card Fail; 2006 Sep; 12(7):491-8. PubMed ID: 16952781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy.
    Stull LB; Leppo MK; Szweda L; Gao WD; Marbán E
    Circ Res; 2004 Nov; 95(10):1005-11. PubMed ID: 15499028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
    Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
    J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium.
    Kögler H; Fraser H; McCune S; Altschuld R; Marbán E
    Cardiovasc Res; 2003 Sep; 59(3):582-92. PubMed ID: 14499859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
    Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
    J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium sparks in human ventricular cardiomyocytes from patients with terminal heart failure.
    Lindner M; Brandt MC; Sauer H; Hescheler J; Böhle T; Beuckelmann DJ
    Cell Calcium; 2002 Apr; 31(4):175-82. PubMed ID: 12027382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subendocardial increase in reactive oxygen species production affects regional contractile function in ischemic heart failure.
    Andre L; Fauconnier J; Reboul C; Feillet-Coudray C; Meschin P; Farah C; Fouret G; Richard S; Lacampagne A; Cazorla O
    Antioxid Redox Signal; 2013 Mar; 18(9):1009-20. PubMed ID: 22978600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.
    Baldus S; Müllerleile K; Chumley P; Steven D; Rudolph V; Lund GK; Staude HJ; Stork A; Köster R; Kähler J; Weiss C; Münzel T; Meinertz T; Freeman BA; Heitzer T
    Free Radic Biol Med; 2006 Oct; 41(8):1282-8. PubMed ID: 17015175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.
    Qin F; Simeone M; Patel R
    Free Radic Biol Med; 2007 Jul; 43(2):271-81. PubMed ID: 17603936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy.
    Xydas S; Kherani AR; Chang JS; Klotz S; Hay I; Mutrie CJ; Moss GW; Gu A; Schulman AR; Gao D; Hu D; Wu EX; Wei C; Oz MC; Wang J
    J Pharmacol Exp Ther; 2006 May; 317(2):553-61. PubMed ID: 16421285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
    Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
    J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
    Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V; Pirolli TJ; Bish LT; Berry MF; Burdick J; Grand T; Woo YJ
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
    Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
    Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective excitation-contraction coupling in hearts of rats with congestive heart failure.
    Sjaastad I; Birkeland JA; Ferrier G; Howlett S; Skomedal T; Bjørnerheim R; Wasserstrom JA; Sejersted OM
    Acta Physiol Scand; 2005 May; 184(1):45-58. PubMed ID: 15847643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.